Eisenbach L - Search Results

1

Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth.

Issaeva I, Zonis Y, Rozovskaia T, Orlovsky K, Croce CM, Nakamura T, Mazo A, Eisenbach L, Canaani E. Issaeva I, et al. Among authors: eisenbach l. Mol Cell Biol. 2007 Mar;27(5):1889-903. doi: 10.1128/MCB.01506-06. Epub 2006 Dec 18. Mol Cell Biol. 2007. PMID: 17178841 Free PMC article.

2

KBF1 (p50 NF-kappa B homodimer) acts as a repressor of H-2Kb gene expression in metastatic tumor cells.

Plaksin D, Baeuerle PA, Eisenbach L. Plaksin D, et al. Among authors: eisenbach l. J Exp Med. 1993 Jun 1;177(6):1651-62. doi: 10.1084/jem.177.6.1651. J Exp Med. 1993. PMID: 8496683 Free PMC article.

3

MHC class I genes controlling the metastatic phenotype of tumor cells.

Feldman M, Eisenbach L. Feldman M, et al. Among authors: eisenbach l. Semin Cancer Biol. 1991 Oct;2(5):337-46. Semin Cancer Biol. 1991. PMID: 1773049 Review.

4

The c-fos proto-oncogene in murine 3LL carcinoma clones controls the expression of MHC genes.

Kushtai G, Barzilay J, Feldman M, Eisenbach L. Kushtai G, et al. Among authors: eisenbach l. Oncogene. 1988 Feb;2(2):119-27. Oncogene. 1988. PMID: 2453011

5

Antimetastatic vaccination against Lewis lung carcinoma with autologous tumor cells modified to express murine interleukin 12.

Popovic D, El-Shami KM, Vadai E, Feldman M, Tzehoval E, Eisenbach L. Popovic D, et al. Among authors: eisenbach l. Clin Exp Metastasis. 1998 Oct;16(7):623-32. doi: 10.1023/a:1006508413070. Clin Exp Metastasis. 1998. PMID: 9932609

6

Differentiation patterns of CD4/CD8 thymocyte subsets in cocultures of fetal thymus and lymphohemopoietic cells from c-fos transgenic and normal mice.

Fridkis-Hareli M, Abel L, Eisenbach L, Globerson A. Fridkis-Hareli M, et al. Among authors: eisenbach l. Cell Immunol. 1992 May;141(2):279-92. doi: 10.1016/0008-8749(92)90148-i. Cell Immunol. 1992. PMID: 1576652

7

The human 1-8D gene (IFITM2) is a novel p53 independent pro-apoptotic gene.

Daniel-Carmi V, Makovitzki-Avraham E, Reuven EM, Goldstein I, Zilkha N, Rotter V, Tzehoval E, Eisenbach L. Daniel-Carmi V, et al. Among authors: eisenbach l. Int J Cancer. 2009 Dec 15;125(12):2810-9. doi: 10.1002/ijc.24669. Int J Cancer. 2009. PMID: 19544527

8

c-fos and c-jun overexpression in malignant cells reduces their tumorigenic and metastatic potential, and affects their MHC class I gene expression.

Yamit-Hezi A, Plaksin D, Eisenbach L. Yamit-Hezi A, et al. Among authors: eisenbach l. Oncogene. 1994 Apr;9(4):1065-79. Oncogene. 1994. PMID: 8134110

9

Expression of two H-2K genes, syngeneic and allogeneic, as a strategy for potentiating immune recognition of tumor cells.

Mandelboim O, Vadai E, Feldman M, Eisenbach L. Mandelboim O, et al. Among authors: eisenbach l. Gene Ther. 1995 Dec;2(10):757-65. Gene Ther. 1995. PMID: 8750016

10

Modification of PDGFalpha receptor expression or function alters the metastatic phenotype of 3LL cells.

Fitzer-Attas CJ, Do MS, Feigelson S, Vadai E, Feldman M, Eisenbach L. Fitzer-Attas CJ, et al. Among authors: eisenbach l. Oncogene. 1997 Sep 25;15(13):1545-54. doi: 10.1038/sj.onc.1201321. Oncogene. 1997. PMID: 9380406

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

129 results

Search Page

Filters